Centro Hospitalar Do Baixo Vouga E.P.E. (CHBV E.P.E.)
- Address
- lock Available on a paid plan
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
The trial at Centro Hospitalar Do Baixo Vouga E.P.E. explores a new selatogrel therapy that patients can self‑administer when they experience symptoms of acute myocardial infarction. The goal is to determine whether early, patient‑driven treatment reduces the likelihood of a recurrent heart attack.
- Patient‑initiated emergency medication
- Evaluation of rapid symptom response
- Impact on recurrent heart attack rates
Findings could shape future emergency protocols for individuals at high cardiovascular risk.
OCEAN(a)-Outcomes – Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction
Researchers at Centro Hospitalar Do Baixo Vouga E.P.E. are testing olpasiran to see if lowering lipoprotein(a) can decrease the incidence of coronary heart disease death, myocardial infarction, or urgent revascularisation in patients with atherosclerotic cardiovascular disease. The study compares the drug to placebo to assess long‑term cardiovascular risk reduction.
- Lp(a) lowering strategy
- Prevention of major cardiac events
- Placebo‑controlled efficacy assessment
Successful results may provide a novel preventative option for people with elevated Lp(a) levels.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 13 therapeutic areas and 15 of 78 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 73 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 17 by active trials.
lock +16 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +10 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 84 other sites in Portugal
Therapeutic Area Benchmark — Portugal
Select a therapeutic area to compare against other sites in Portugal.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Portugal
Market Share
Country: Portugal
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro Hospitalar Do Baixo Vouga E.P.E. (CHBV E.P.E.)
lock Showing 1 of 41 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study) | Viiv Healthcare UK Limited | Phase II | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 78 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Itepekimab | 5 | Unknown | 2021-04-08 | 2026-06-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.